|
Search
Collections
Benchmarks
Upload document
PMB
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Weekly paclitaxel (P), carboplatin (CP) plus pembrolizumab (PMB) as first-line treatment of recurrent or metastatic (R/M) or locally very advanced (LVA) head and neck squamous cell carcinoma (HNSCC): A retrospective study in 39 patients (pts).
Org:
Institut de Cancérologie Strasbourg Europe,